3NW5
Crystal structure of insulin-like growth factor 1 receptor (IGF-1R-WT) complex with a carbon-linked proline isostere inhibitor (11B)
Summary for 3NW5
| Entry DOI | 10.2210/pdb3nw5/pdb |
| Related | 3NW6 3NW7 |
| Descriptor | Insulin-like growth factor 1 receptor, N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-{(2R)-1-[(6-fluoropyridin-3-yl)carbonyl]pyrrolidin-2-yl}pyrrolo[2,1-f][1,2,4]triazin-4-amine (3 entities in total) |
| Functional Keywords | hormone/growth factor, igf-1r, kinase domain, transferase |
| Biological source | Homo sapiens (human) |
| Cellular location | Membrane; Single-pass type I membrane protein: P08069 |
| Total number of polymer chains | 1 |
| Total formula weight | 35473.68 |
| Authors | Sack, J.S. (deposition date: 2010-07-09, release date: 2010-07-28, Last modification date: 2024-02-21) |
| Primary citation | Sampognaro, A.J.,Wittman, M.D.,Carboni, J.M.,Chang, C.,Greer, A.F.,Hurlburt, W.W.,Sack, J.S.,Vyas, D.M. Proline isosteres in a series of 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitors of IGF-1R kinase and IR kinase. Bioorg.Med.Chem.Lett., 20:5027-5030, 2010 Cited by PubMed Abstract: Pyrrolidine, pyrrolidinone, carbocyclic, and acyclic groups were used as isosteric proline replacements in a series of insulin-like growth factor I receptor kinase/insulin receptor kinase inhibitors. Examples that were similar in potency to proline-containing reference compounds were shown to project a key fluoropyridine amide into a common space, while less potent compounds were not able to do so for reasons of stereochemistry or structural rigidity. PubMed: 20675137DOI: 10.1016/j.bmcl.2010.07.045 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.14 Å) |
Structure validation
Download full validation report
